Published 2022
| Version v1
Publication
Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study
Creators
- Macaluso, Fabio Salvatore
- Principi, Mariabeatrice
- Facciotti, Federica
- Contaldo, Antonella
- Todeschini, Alessia
- Saibeni, Simone
- Bezzio, Cristina
- Castiglione, Fabiana
- Nardone, Olga Maria
- Spagnuolo, Rocco
- Fantini, Massimo Claudio
- Riguccio, Gaia
- Caprioli, Flavio
- Viganò, Chiara
- Felice, Carla
- Fiorino, Gionata
- Correale, Carmen
- Bodini, Giorgia
- Milla, Monica
- Scardino, Giulia
- Vernero, Marta
- Desideri, Federico
- Mannino, Mariella
- Rizzo, Giuseppe
- Orlando, Ambrogio
Contributors
Others:
- Macaluso, Fabio Salvatore
- Principi, Mariabeatrice
- Facciotti, Federica
- Contaldo, Antonella
- Todeschini, Alessia
- Saibeni, Simone
- Bezzio, Cristina
- Castiglione, Fabiana
- Nardone, Olga Maria
- Spagnuolo, Rocco
- Fantini, Massimo Claudio
- Riguccio, Gaia
- Caprioli, Flavio
- Viganò, Chiara
- Felice, Carla
- Fiorino, Gionata
- Correale, Carmen
- Bodini, Giorgia
- Milla, Monica
- Scardino, Giulia
- Vernero, Marta
- Desideri, Federico
- Mannino, Mariella
- Rizzo, Giuseppe
- Orlando, Ambrogio
Description
Patients on immunosuppressive drugs have been excluded from COVID-19 vaccines trials, creating concerns regarding their efficacy.
Additional details
Identifiers
- URL
- http://hdl.handle.net/11567/1096416
- URN
- urn:oai:iris.unige.it:11567/1096416
Origin repository
- Origin repository
- UNIGE